CIK 0001802369 · Non-accelerated filer<br>Smaller reporting company<br>Emerging growth company
ADARx Pharmaceuticals, Inc.
Sign in to watch- Ticker
- ADRX
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 844145188
- Phone
- 858-283-9472
- Business address
- 5871 OBERLIN DRIVE, SUITE 200, SAN DIEGO, CA, 92121
- SCHEDULE 13G Stake Statement of Beneficial Ownership
- 10-Q Report Quarterly Report
- 8-K Event Results of operations · Regulation FD disclosure
- SCHEDULE 13G Stake Statement of Beneficial Ownership
- SCHEDULE 13D Stake Beneficial Ownership Report
- SCHEDULE 13D Stake Beneficial Ownership Report
- SCHEDULE 13G Stake Statement of Beneficial Ownership
- 4 Open-market buy Director bought 61,516 shares at $17.00 ($1,045,772)
- 4 Open-market buy Director bought 950,000 shares at $17.00 ($16,150,000)
- 4 Open-market buy Director bought 950,000 shares at $17.00 ($16,150,000)
- 4 Open-market buy 10% owner bought 1,600,000 shares at an average $17.00 ($27,200,000)
- 4 Open-market buy Director bought 1,600,000 shares at an average $17.00 ($27,200,000)
- 4 Conversion 10% owner acquired 11,858,655 shares (conversion)
- S-8 Other Securities Offered to Employees in Benefit Plans
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 8-K Event Unregistered share sale · Bylaws or fiscal year change · Other events
Page 1 of 3 · 50 filings